Top Biotechnology companies in Denmark by Operating Income

This ranking features the top 15 Biotechnology companies in Denmark ranked by Operating Income, totalling a Operating Income of USD 1.46 B, for January 15, 2025.
#
Name
Operating Income
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 787.61 M
Dec. 31, 2023 USD 216.88 1.28%

Denmark

2
USD 588.53 M
Dec. 31, 2023 USD 54.16 -1.39%

Denmark

3
USD 472.92 M
Dec. 31, 2023 USD 5.46 0.56%

Denmark

4
USD 221.66 M
Dec. 31, 2023 USD 26.62 -0.36%

Denmark

5
USD 25.74 M
June 30, 2024 USD 70.50 0.61%

Denmark

6
USD -4.00 K
Dec. 31, 2023 USD 0.64 1.38%

Denmark

7
USD -1.61 M
Dec. 31, 2023 USD 0.63 -3.68%

Denmark

8
USD -1.86 M
Dec. 31, 2023 USD 1.93 -6.19%

Denmark

9
USD -6.46 M
Dec. 31, 2023 USD 3.98 0.01%

Denmark

10
USD -7.31 M
Dec. 31, 2023 USD 91.43 -1.85%

Denmark

11
USD -8.00 M
Dec. 31, 2023 USD 0.57 1.47%

Denmark

12
USD -9.05 M
Dec. 31, 2023 USD 0.20 -2.77%

Denmark

13
USD -10.46 M
Dec. 31, 2023 USD 2.17 5.88%

Denmark

14
USD -84.70 M
Dec. 31, 2023 USD 95.84 0.08%

Denmark

15
USD -502.80 M
Dec. 31, 2023 USD 131.57 -1.84%

Denmark

Frequently Asked Questions
  • Which Biotechnology company in Denmark has the highest Operating Income ?

    The Biotechnology company in Denmark with the highest Operating Income is Genmab A/S (Copenhagen Stock Exchange: GMAB.CO) at USD 787.61 M.

  • Which Biotechnology company in Denmark has the lowest Operating Income ?

    The Biotechnology company in Denmark with the lowest Operating Income is Ascendis Pharma A/S (NasdaqGS: ASND) at USD -502.80 M.